Acellera is a pioneer in applying state of the art technologies to simulations for the study of biophysical phenomena and the support of drug discovery and design. Founded in 2006, it was one of the first companies worldwide to leverage the use of novel accelerator processor technology (GPU). Over the last 13 years, Acellera has focused on developing software and hardware solutions that optimize the efficiency and throughput of molecular dynamics simulations, as well as the analysis of large data. Its most recent project is PlayMolecule (www.playmolecule.com), a repository of machine learning applications for drug discovery.